Floatz logo

HUMAN CULTURE ENRICHED/EXPANDED AUTOLOGOUS EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS (EBV-CTL) DERIVED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) FOR CELL-BASED THERAPY. CELLS ARE GENERATED BY COCULTURE WITH GAMMA IRRADIATED AUTOLOGOUS LYMPHOBLASTOID CELL LINES (LCL) AND INTERLEUKIN-2 (IL-2) STIMULATION

Multiple Myeloma and Plasma Cell Neoplasm

Northwestern UniversityCell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

498 Active assets in the Multiple Myeloma and Plasma Cell Neoplasm cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Jonsson Comprehensive Cancer Center
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 4BBB
Inno-206
University of Arkansas
Phase 3BBB
Hyaluronidase fihj
Massachusetts General Hospital
Phase 4BBB
Filanesib
PETHEMA Foundation
Phase 2BBB

View all 50 →

Same molecule, other indications

HUMAN CULTURE ENRICHED/EXPANDED AUTOLOGOUS EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS (EBV-CTL) DERIVED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) FOR CELL-BASED THERAPY. CELLS ARE GENERATED BY COCULTURE WITH GAMMA IRRADIATED AUTOLOGOUS LYMPHOBLASTOID CELL LINES (LCL) AND INTERLEUKIN-2 (IL-2) STIMULATION is also rated in:

leukemiaDormant
CCC
Indicative ·
51 / 100
View asset →
lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
non-Hodgkin lymphomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →